ArticleBMJ open2021
Predicting the risk of cancer in adults using supervised machine learning: a scoping review.
Article in BMJ open, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed.
- Deep learning for incidence rate prediction and radiation risk assessment of solid tumors.Scientific reports · 2026Article
- A Machine Learning Risk Prediction Model for Gastric Cancer with SHapley Additive exPlanations.Cancer research and treatment · 2025Article
- Machine learning algorithms that predict the risk of prostate cancer based on metabolic syndrome and sociodemographic characteristics: a prospective cohort study.BMC public health · 2024Article
- ASSIGN score and cancer risk in the Scottish Heart Health Extended Cohort (SHHEC) study.BJC reports · 2024Article
- Using real-world electronic health record data to predict the development of 12 cancer-related symptoms in the context of multimorbidity.JAMIA open · 2024Article
- Cryptogenic Stroke and Migraine: Using Probabilistic Independence and Machine Learning to Uncover Latent Sources of Disease from the Electronic Health Record.AMIA ... Annual Symposium proceedings. AMIA Symposium · 2024Article
- Data Science as a Core Competency in Undergraduate Medical Education in the Age of Artificial Intelligence in Health Care.JMIR medical education · 2023Article
- Deep learning for predicting future lesion emergence in high-risk breast MRI screening: a feasibility study.European radiology experimental · 2023Article
- Establishing machine learning models to predict the early risk of gastric cancer based on lifestyle factors.BMC gastroenterology · 2023Article
- Creation and Evaluation of the Illinois Cancer Risk Index as a Predictor of Four Common Cancers.Preventing chronic disease · 2022Article
- Prediction of early-stage melanoma recurrence using clinical and histopathologic features.NPJ precision oncology · 2022Article
- Article
- Effective hybrid feature selection using different bootstrap enhances cancers classification performance.BioData mining · 2022Article
- Assessment of the Predictive Value of Spectrophotometric Skin Color Parameters and Environmental and Behavioral Factors in Estimating the Risk of Skin Cancer: A Case-Control Study.Journal of clinical medicine · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
objectivesThe purpose of this scoping review is to: (1) identify existing supervised machine learning (ML) approaches on the prediction of cancer in asymptomatic adults; (2) to compare the performance of ML models with each other and (3) to identify potential gaps in research.
designScoping review using the population, concept and context approach. SEARCH STRATEGY: PubMed search engine was used from inception to 10 November 2020 to identify literature meeting following inclusion criteria: (1) a general adult (≥18 years) population, either sex, asymptomatic (population); (2) any study using ML techniques to derive predictive models for future cancer risk using clinical and/or demographic and/or basic laboratory data (concept) and (3) original research articles conducted in all settings in any region of the world (context).
resultsThe search returned 627 unique articles, of which 580 articles were excluded because they did not meet the inclusion criteria, were duplicates or were related to benign neoplasm. Full-text reviews were conducted for 47 articles and a final set of 10 articles were included in this scoping review. These 10 very heterogeneous studies used ML to predict future cancer risk in asymptomatic individuals. All studies reported area under the receiver operating characteristics curve (AUC) values as metrics of model performance, but no study reported measures of model calibration.
conclusionsResearch gaps that must be addressed in order to deliver validated ML-based models to assist clinical decision-making include: (1) establishing model generalisability through validation in independent cohorts, including those from low-income and middle-income countries; (2) establishing models for all cancer types; (3) thorough comparisons of ML models with best available clinical tools to ensure transparency of their potential clinical utility; (4) reporting of model calibration performance and (5) comparisons of different methods on the same cohort to reveal important information about model generalisability and performance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.